Compare APOG & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APOG | FLGT |
|---|---|---|
| Founded | 1949 | 2011 |
| Country | United States | United States |
| Employees | N/A | 1313 |
| Industry | Auto Parts:O.E.M. | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 820.9M | 867.4M |
| IPO Year | N/A | 2016 |
| Metric | APOG | FLGT |
|---|---|---|
| Price | $38.79 | $27.52 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $47.00 | $28.33 |
| AVG Volume (30 Days) | 156.6K | ★ 245.4K |
| Earning Date | 01-07-2026 | 11-07-2025 |
| Dividend Yield | ★ 2.58% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.05 | N/A |
| Revenue | ★ $1,391,854,000.00 | $315,549,000.00 |
| Revenue This Year | $5.66 | $16.84 |
| Revenue Next Year | $0.83 | $9.74 |
| P/E Ratio | $19.60 | ★ N/A |
| Revenue Growth | 1.19 | ★ 13.61 |
| 52 Week Low | $32.77 | $14.57 |
| 52 Week High | $76.72 | $31.04 |
| Indicator | APOG | FLGT |
|---|---|---|
| Relative Strength Index (RSI) | 54.96 | 50.51 |
| Support Level | $39.78 | $26.63 |
| Resistance Level | $41.00 | $28.26 |
| Average True Range (ATR) | 1.02 | 0.73 |
| MACD | 0.21 | -0.23 |
| Stochastic Oscillator | 50.47 | 40.04 |
Apogee Enterprises Inc is a provider of architectural products and services for enclosing buildings, and high-performance glass and acrylic products used in applications for preservation, protection, and enhanced viewing. The company's operating segment consists of the Architectural Metals Segment, Architectural Services Segment, Architectural Glass Segment, and Performance Surfaces Segment. The company generates the majority of its revenue from the Architectural Metals Segment, which designs, engineers, fabricates, and finishes aluminum window, curtainwall, storefront, and entrance systems used principally in non-residential construction. The company generates revenue geographically from the United States, Canada, and Brazil, with the majority coming from the United States.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.